Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-20 Sale | 2021-08-24 5:12 pm | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 4,000 | $8.7854 | $35,142 | 132,346 (Direct) | View |
| 2021-06-11 Sale | 2021-06-14 6:18 pm | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 4,000 | $9.4368 | $37,747 | 136,346 (Direct) | View |
| 2021-04-21 Sale | 2021-04-23 8:49 pm | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 4,000 | $8.438 | $33,752 | 269,207 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-01 Option Award | 2022-03-01 7:28 pm | N/A 2032-02-29 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 122,568 | $0 | 184,053 (Direct) | View |
| 2021-12-06 Exercise | 2021-12-08 8:38 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 10,000 | $1.322 | 132,346 (Direct) | View |
| 2021-12-06 Exercise | 2021-12-08 8:38 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 10,000 | $0 | 132,346 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-10 4:19 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 10,000 | $1.322 | 132,346 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-10 4:19 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 10,000 | $0 | 132,346 (Direct) | View |
| 2021-08-20 Exercise | 2021-08-24 5:12 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 4,000 | $1.322 | 132,346 (Direct) | View |
| 2021-08-20 Exercise | 2021-08-24 5:12 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 4,000 | $0 | 132,346 (Direct) | View |
| 2021-07-28 Exercise | 2021-07-30 4:29 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 20,000 | $1.322 | 136,346 (Direct) | View |
| 2021-07-28 Exercise | 2021-07-30 4:29 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 20,000 | $0 | 136,346 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 8:02 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 5,000 | $1.322 | 136,346 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 8:02 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 5,000 | $0 | 136,346 (Direct) | View |
| 2021-06-11 Exercise | 2021-06-14 6:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 4,000 | $1.322 | 136,346 (Direct) | View |
| 2021-06-11 Exercise | 2021-06-14 6:18 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 4,000 | $0 | 136,346 (Direct) | View |
| 2021-04-21 Exercise | 2021-04-23 8:49 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 9,000 | $1.322 | 269,207 (Direct) | View |
| 2021-04-21 Exercise | 2021-04-23 8:49 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 9,000 | $0 | 269,207 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 4:52 pm | N/A 2031-02-03 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 164,000 | $0 | 164,000 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-19 5:00 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 7,564 | $1.322 | 144,346 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-19 5:00 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 7,564 | $0 | 144,346 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-11 5:00 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 3,921 | $1.322 | 144,346 (Direct) | View |
| 2021-01-08 Exercise | 2021-01-11 5:00 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 3,921 | $0 | 144,346 (Direct) | View |
Ownership | 2020-07-09 6:00 pm | N/A 2026-06-19 | Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer | 0 | $0 | 360,865 (Direct) | View |